Company: Scilex Holding Co
Form Type: 8-K
Filing Date: 2024-10-28
Corporate Action: Spin-off
Type: Update
Accession Number: 000095017024117557
Comments: Scilex Holding Company has announced a dividend, constituting a spin-off involving the Series 1 Mandatory Exchangeable Preferred Stock. This dividend will allow holders to partake in an exchange connected to shares of its subsidiary, Semnur Pharmaceuticals, Inc. The announcement includes details about the dividend distribution that will take place on the Record Date of November 7, 2024, with shares being subject to specific transfer restrictions. The board emphasizes the strategic efforts to maximize value for stockholders through this spin-off while ensuring compliance with necessary regulations.
Document Link: View Document
Additional details:
Newco Cik: 1584541
Parent Cik: 1820190
File Number: 001-39852
Access 12: 000095017024
: 0
Effective Date: 2024-06-17
Spin Off Id: 784
Form Type: 8-K
Filing Date: 2024-10-08
Corporate Action: Spin-off
Type: Update
Accession Number: 000119312524234244
Comments: The announcement pertains to a securities purchase agreement involving Scilex Holding Company and Oramed Pharmaceuticals Inc., but it does not involve a spin-off. The transactions include the issuance of convertible notes and warrants, and refinances existing debts.
Document Link: View Document
Additional details:
Newco Cik: 1584541
Parent Cik: 1820190
File Number: 001-39852
Access 12: 000119312524
: 0
Effective Date: 2024-06-17
Spin Off Id: 784
Form Type: 8-K
Filing Date: 2024-07-02
Corporate Action: Spin-off
Type: Update
Accession Number: 000095017024080768
Comments: The document discusses the possibility of conducting a spin-off as part of the company's strategic plans regarding Semnur Pharmaceuticals, Inc., indicating it is not a completed spin-off but is being considered.
Document Link: View Document
Additional details:
Newco Cik: 1584541
Parent Cik: 1820190
File Number: 001-39852
Access 12: 000095017024
: 0
Effective Date: 2024-06-17
Spin Off Id: 784
Form Type: 8-K
Filing Date: 2024-06-28
Corporate Action: Spin-off
Type: Update
Accession Number: 000095017024078800
Comments: The document discusses a potential spin-off involving Semnur Pharmaceuticals, Inc.
Document Link: View Document
Additional details:
Newco Cik: 1584541
Parent Cik: 1820190
File Number: 001-39852
Access 12: 000095017024
: 0
Effective Date: 2024-06-17
Spin Off Id: 784
Form Type: 8-K
Filing Date: 2024-06-17
Corporate Action: Spin-off
Type: New
Accession Number: 000119312524162568
Comments: The document discusses the Board of Directors of Scilex Holding Company authorizing management to explore options to maximize the value of Semnur Pharmaceuticals, Inc., including a spin-off, merger, or similar transaction.
Document Link: View Document
Additional details:
Newco Cik: 1584541
Parent Cik: 1820190
File Number: 001-39852
:
Effective Date: 2024-06-17